A company disclosed a stake purchase to the SEC, concurrent with Bank of America increasing its holdings in AstraZeneca stock.
1 report, 1 independent
Updated Jul 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company disclosed a stake purchase to the SEC, concurrent with Bank of America increasing its holdings in AstraZeneca stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Analysts are monitoring the performance and pipeline risks of AstraZeneca, following concurrent stake purchases and increased holdings by Bank of America.Sub-event
Stake purchase disclosed to SEC; Bank of America increased holdings in AstraZeneca.1 source
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
SEC
Slovak company
-
Bank of America
American multinational banking and financial services corporation
Related events
- A company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.
- Data I/O Corporation filed acquisition documents with the SEC following significant stock purchases by major shareholders and institutional investors.
- AstraZeneca listed shares on the New York Stock Exchange to attract investors.
- Monolithic Power Systems filed disclosures with the SEC, listed on Nasdaq, and saw Royal Bank of Canada increase its stock stake.
- Shell disclosed its holdings to the SEC on September 8, 2026.